The Fraser Institute: Media Advisory; New Report Comparing Health Canada Drug Approval Times to That of European, U.S. Agencies Coming Thursday, April 25


CALGARY, ALBERTA--(Marketwired - Apr 24, 2013) - The Fraser Institute will release a new report measuring the length of time it takes Health Canada to approve patented new medicines for public use, on Thursday, April 25 at 6:30 a.m. (Eastern).

Federal Delays in Approving New Medicines compares the speed of Health Canada to that of the European Medicines Agency and the United States Food and Drug Administration in certifying new prescription drugs as safe and effective from 2007 to 2011.

A news release with additional information will be issued via Marketwire at 6:30 a.m. (Eastern) on Thursday, April 25.

The full report will also be available as a free PDF download at

Follow the Fraser Institute on Twitter and Facebook

The Fraser Institute is an independent Canadian public policy research and educational organization with offices in Vancouver, Calgary, Toronto, and Montreal and ties to a global network of 86 think-tanks. Its mission is to measure, study, and communicate the impact of competitive markets and government intervention on the welfare of individuals. To protect the Institute's independence, it does not accept grants from governments or contracts for research. Visit

The Fraser Institute
Nadeem Esmail
Director of Health Policy Studies
(403) 216-7175 ext. 422
Twitter: @NadeemEsmail
The Fraser Institute
Kendal Egli
Communications Specialist
(416) 363-6575 ext. 235

View Comments (0)